In the last trading session, 2.39 million shares of the Cns Pharmaceuticals Inc (NASDAQ:CNSP) were traded, and its beta was 1.06. Most recently the company’s share price was $0.11, and it changed around $0.0 or 2.06% from the last close, which brings the market valuation of the company to $6.28M. CNSP currently trades at a discount to its 52-week high of $101.78, offering almost -92427.27% off that amount. The share price’s 52-week low was $0.10, which indicates that the current value has risen by an impressive 9.09% since then. We note from Cns Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 3.55 million shares, with the 3-month average coming to 15.29 million.
Cns Pharmaceuticals Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended CNSP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Instantly CNSP has showed a green trend with a performance of 2.06% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.1124 on recent trading dayincreased the stock’s daily price by 2.14%. The company’s shares are currently down -99.83% year-to-date, but still up 5.41% over the last five days. On the other hand, Cns Pharmaceuticals Inc (NASDAQ:CNSP) is -6.51% down in the 30-day period. We can see from the shorts that 1.14 million shares have been sold at a short interest cover period of 0.04 day(s).
The consensus price target as assigned by Wall Street analysts is $0.5, which translates to bulls needing to increase their stock price by 78.0% from its current value. Analyst projections state that CNSP is forecast to be at a low of $0.5 and a high of $0.5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.98%.
CNSP Dividends
Cns Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.04% of Cns Pharmaceuticals Inc shares, and 0.79% of them are in the hands of institutional investors. The stock currently has a share float of 0.80%.
